CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net loss	$ (780,053)	$ (2,000,196)	$ (1,618,057)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	12,958	39,046	38,220
Loss on the sale of other assets	36,626		36,626
Loss on debt modifications			131,944
Amortization of original issue discount			22,500
Amortization of debt discount		294,888	308,534
Amortization of debt offering costs	9,131		20,000
Derivative expense	66,980		66,980
Stock issued for services - related party		159,930	183,693
Stock issued for services		407,000	194,215
Change in fair value of derivative liability	(44,661)		44,661
Change in operating liability:
Decrease in deferred rent		(1,705)	(696)
Decrease in accounts receivable		34,853	59,200
(Increase) decrease in other receivable		7,323	(7,323)
Decrease in inventory			4,292
Decrease in prepaid expense			1,697
Increase in accounts payable and accrued expenses		41,572	24,669
Increase (decrease) in accrued payroll		(3,420)	4,327
Increase (decrease) in costs and estimated earnings in excess of billings		(20,155)	15,049
Decrease in accrued compensation			(3,470)
Net cash used in operating activities		(1,040,864)	(472,939)
Cash flows from investing activities:
Proceeds from sale of equipment			10,000
Purchase of equipment and software		(550)	(6,988)
Net cash provided by (used in) investing activities		(550)	3,012
Cash flows from financing activities:
Repayments of note payable		(230,526)	(4,539)
Proceeds from convertible note payable, less offerings costs and OID costs paid			230,000
Repayment of convertible note		(175,000)	(201,093)
Proceeds from demand note payable, less OID costs paid		250,000	204,000
Issuance of preferred stock for cash		300,001	125,000
Issuance of common stock for cash		824,000	50,000
Net cash provided by financing activities		968,474	403,368
Decrease cash and cash equivalents		(72,940)	(66,559)
Cash and cash equivalents at beginning of period		78,219	100,906
Cash and cash equivalents at end of period	$ 34,347	5,279	34,347
Cash paid during the period for:
Interest		1,917	2,405
Income taxes		0	0
Supplemental disclosure of non-cash investing and financing activities:
Beneficial conversion feature		95,333	154,416
Shares issued for debt issuance costs			143,500
Shares issued on conversion of convertible debt			103,351
Reclass of promissory note to convertible note			$ 203,351
Settlement of convertible note into common shares		100,000
Conversion of preferred shares into common shares		2,500
Shares issued due to merger with Alamo CBD		$ 890,961